Hemagglutination and antigenic comparison of rabbit hemorrhagic disease virus

The hemagglutinating activity and serological properties of three strains of rabbit hemorrhagic disease virus, Chinese, Korean and Shizuoka, which was first isolated in Japan, were examined by hemagglutination (HA) and cross hemagglutination inhibition (HI) test with human erythrocytes. Similar results were observed between the Chinese and Korean strains, both of which gave positive HA at 4 degrees C with O, A, B and AB, and at 22 degrees C with B and AB blood groups. In the Shizuoka strain, positive HA was observed at 4 degrees C with O, A, B and AB, at 22 degrees C with A, B And AB, and at 37 degrees C with B blood group. In experimentally infected rabbits, HI antibody in these animals showed a titer of 16,384 or 32,768 at 4 weeks after inoculation. No serological difference was observed in three strains by cross HI test.     

Comparison of feline parvovirus subspecific strains using monoclonal antibodies against a feline panleukopenia virus

Four monoclonal antibodies (mAb) against a feline panleukopenia virus (FPLV) TU 1 strain, one of the host range variants of feline parvovirus (FPV), were produced and applied for antigenic analysis of FPLV, canine parvovirus (CPV) and mink enteritis virus (MEV). All mAbs were considered to be directed at epitopes on the virus capsid surface because they neutralized the infectivity and inhibited the hemagglutination (HA) of the homologous virus as well as other FPV strains. They were of the mouse IgG1 type. High antigenic homogeneity among FPLV strains was confirmed by HA-inhibition (HI) test with the mAbs and polyclonal immune sera against FPLV or CPV. But the TU 11 strain of FPLV was antigenically distinguished from the remaining 14 FPLV strains by both the HI test and the micro-neutralization test with one of the mAbs produced. MEV Abashiri strain was found to be antigenically indistinguishable from FPLV. Most of the CPV strains isolated after 1981 were considered to be antigenically different from earlier CPV isolates when some mAbs were applied in the serological tests, confirming the replacement of CPV by an antigenic variant in Japan. However, antigenically different CPVs were detected at the end of 1984 from unrelated epizootics occurred a month apart in the same area.     

Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals

In general, avian influenza (AI) vaccines protect chickens from morbidity and mortality and reduce, but do not completely prevent, replication of wild AI viruses in the respiratory and intestinal tracts of vaccinated chickens. Therefore, surveillance programs based on serological testing must be developed to differentiate vaccinated flocks infected with wild strains of AI virus from noninfected vaccinated flocks in order to evaluate the success of vaccination in a control program and allow continuation of national and international commerce of poultry and poultry products. In this study, chickens were immunized with a commercial recombinant fowlpox virus vaccine containing an H5 hemagglutinin gene from A/turkey/Ireland/83 (H5N8) avian influenza (AI) virus (rFP-H5) and evaluated for correlation of immunological response by hemagglutination inhibition (HI) or agar gel immunodiffusion (AGID) tests and determination of protection following challenge with a high pathogenicity AI (HPAI) virus. In two different trials, chickens immunized with the rFP-H5 vaccine did not develop AGID antibodies because the vaccine lacks AI nucleoprotein and matrix genes, but 0%-100% had HI antibodies, depending on the AI virus strain used in the HI test, the HI antigen inactivation procedure, and whether the birds had been preimmunized against fowlpox virus. The most consistent and highest HI titers were observed when using A/turkey/Ireland/83 (H5N8) HPAI virus strain as the beta-propiolactone (BPL)-inactivated HI test antigen, which matched the hemagglutinin gene insert in the rFP-H5 vaccine. In addition, higher HI titers were observed if ether or a combination of ether and BPL-inactivated virus was used in place of the BPL-inactivated virus. The rFP-H5 vaccinated chickens survived HPAI challenge and antibodies were detected by both AGID and HI tests. In conclusion, we demonstrated that the rFP-H5 vaccine allowed easy serological differentiation of infected from noninfected birds in vaccinated populations of chickens when using standard AGID and HI tests.     

猪传染性胃肠炎病毒的血凝位点的定位研究

通过转瓶培养ＩＢＲＳ２细胞，选择最佳接毒剂量、接毒时间和收毒时间生产出凝集价（ＨＡ）达２１２的猪传染性胃肠炎病毒（ＴＧＥＶ）血凝抗原。用抗ＴＧＥＶＳ蛋白和 Ｍ蛋白的单克隆抗体与不同稀释度的ＴＧＥＶ血凝抗原等量混合，在 ３７℃作用 ３０分钟后接种ＩＢＲＳ２细胞和做中和试验（ＮＴ）和血凝抑制（ＨＩ）试验。结果表明ＴＧＥＶ血凝位点与中和位点一致，血凝素位于Ｓ蛋白Ａ位点或其附近。     

B型副鸡嗜血杆菌血凝素基因的克隆表达及生物活性鉴定

血凝素是副鸡嗜血杆菌（Haemophilus paragallinarum，Hpg）的主要抗原成分之一，鸡只对Hpg的免疫力与血凝素抗体滴度成正相关。根据GenBank上已发表的B型Hpg Dalian株的血凝素基因序列（AY622378），设计合成了1对特异扩增Hpg血凝素基因的引物。以大连分离株Hpg中提取的细菌DNA为模板，利用PCR扩增出了1038bp的血凝素基因，将其克隆到pET-32a载体上，构建了pET-HA原核表达质粒并在BL21。大肠杆菌中过量表达。血凝试验显示纯化的重组蛋白具有血凝活性；Western试验证明该重组蛋白可以被B型Hpg特异性鸡血清所识别。本研究在国内首次对Hpg的血凝素基因进行克隆表达，并分析了重组蛋白的血凝活性。     

提高鸡传染性支气管炎病毒血凝抗原滴度途径及抗原灭活

将７株传染性支气管炎病毒（ＩＢＶ）标准株（Ｍ４１、Ｈ１２０、Ｈｏｌｔｅ、Ｇｒａｙ、Ｃｏｎｎｅｃｔｉｃｕｔ、Ｉｏｗａ６０９和Ｔ株）和６株分离株（ＮＩＢＶ、ＧＩＢＶ、Ｍ、ＳＨ、Ｊ和Ｈ株）分别接种于鸡胚，收获尿囊液，经浓缩后，用魏氏梭菌培养液处理，制备血凝抗原。其中，Ｈ１２０株血凝滴度最高，Ｔ、Ｍ、Ｊ和Ｈ株无血凝性。应用含有不同滴度ＩＢＶ母源抗体的鸡胚增殖病毒制备抗原，效价与用ＳＰＦ鸡胚增殖病毒制备的抗原效价一致。尿囊液经反复冻融后再制备抗原会使血凝价降低。抗原分别用甲醛、高碘酸钠、硼氢化钾和ＳＤＳ灭活，其中甲醛灭活效果最理想。抗原对氯仿敏感，对乙醚稳定。适宜浓度的Ｎａ＋、Ｍｇ２＋可显著提高抗原的血凝性     

Hemagglutination and hemagglutination inhibition with Chuzan virus.

Chuzan virus agglutinated erythrocytes of several species of animals including bovine. The hemagglutinating (HA) activity against bovine erythrocytes was dependent on NaCl molarity and was expressed best at 0.6 M, but it was independent of pH and temperature. Three strains of Chuzan virus isolated from 2 cows and a pool of culicoides midges had indistinguishable HA antigenicity. All cattle infected with the virus developed high titers of hemagglutination inhibiting (HI) antibody which changed in parallel with neutralizing (NT) antibody titers. Correlation between HI and NT antibodies was very high and the antibodies persisted for one year or more. Therefore it was concluded that the HI test is applicable for survey of Chuzan virus infection among cattle in place of the NT test.     

Hemagglutinating activity and immunological properties of Haemophilus paragallinarum field isolates in Japan

Four field isolates (S4, S10, S15, and S17) of Haemophilus paragallinarum were recovered from chickens affected with infectious coryza in widely separated regions of Japan. Their hemagglutinating (HA) activity and immunological properties were compared with those of strain 221 of serovar A/1 and strains Modesto and S1 of serovar C/2. When treated with potassium thiocyanate or hyaluronidase, all the isolates showed HA activity against formaldehyde-fixed chicken erythrocytes but not against fresh chicken erythrocytes. In the hemagglutination-inhibition (HI) test, the isolates cross-reacted with strains Modesto and S1 but not with strain 221. The immunological properties of these isolates, as determined by cross-protection tests, were similar to those of strain S1 and, to a lesser degree, strain Modesto, but not to strain 221. Our results indicated that the four field isolates belong to serovar C/2 and that the HI test is a suitable method for serotyping H. paragallinarum.     

Induction of antibodies to canine herpesvirus in mice by immunization with anti-idiotypic antibodies.

Anti-idiotypic antibodies (anti-Id Abs) were produced in rabbits after inoculation with two mouse monoclonal antibodies (mAbs) directed against canine herpesvirus (CHV) glycoproteins (gps). One of the mAbs, 12H11, was directed against an epitope on gp 145/112 of CHV which induced virus neutralizing (VN) antibodies and against a cross-reacting epitope on the gp 143/108 of feline herpes-virus type 1 (FHV-1). The other mAb, 11F7, was directed against epitopes on CHV gp47 which induce VN and hemagglutination-inhibition (HAI) antibodies. Using VN-inhibition and HAI-inhibition assays with CHV and FHV-1, the anti-Id Abs obviously inhibited the activities of autologous mAbs, suggesting that anti-Id Abs mimic the epitopes of CHV gp 145/112 or FHV-1 gp 143/108 and CHV gp47 by binding the anti-combining site of the mAbs. These anti-Id Abs, when injected into mice, elicited specific CHV-neutralizing and HAI antibody responses, and one of them also elicited a specific FHV-1-neutralizing antibody response. These data supported the idea that immunization with anti-Id Ab can induce specific VN antibody response, as has been theorized by other workers.     

鸵鸟新城疫病毒野毒株的分离及其生物学特性

用鸡胚从疑似鸵鸟新城疫的送检病料中分离到 2株病毒。 2株病毒均能凝集鸡红细胞 ,且能被抗新城疫病毒 ( NDV)阳性血清抑制 ;用抗 NDV单抗 PEG夹心 ELISA测定 2株分离毒均为阳性。对其中 1株作进一步生物学特性鉴定 ,按照国际上规定的 NDV毒力判定标准测定的该毒株最低致死量致死鸡胚的平均死亡时间 ( MDT)为 54h,1日龄雏鸡脑内接种致病指数 ( ICPI)为 1 .88,6周龄雏鸡静脉接种致病指数 ( IVPI)为2 .75。结果表明 ,本分离株为鸵鸟新城疫病毒强毒     

Porcine reproductive and respiratory syndrome virus: morphological, biochemical and serological characteristics of Quebec isolates associated with acute and chronic outbreaks of porcine reproductive and respiratory syndrome.

Cytolytic and noncytolytic strains of the porcine reproductive and respiratory syndrome virus (PRRSV) were isolated in primary cultures of porcine alveolar macrophages (PAM) from lung homogenates of stillborn fetuses or blood samples of dyspneic piglets collected from Quebec pig farms having experienced acute or chronic outbreaks of PRRS. Serological identification of the virus was confirmed by indirect immunofluorescence and indirect protein A-gold immunoelectron microscopy using reference antiserum prepared from experimentally-infected specific pathogen free (SPF) piglets and monoclonal antibodies (MoAbs) directed against the p15 nucleocapsid (N) protein of the reference ATCC-VR2332 isolate. Intracytoplasmic enveloped viral particles that tended to accumulate into cytoplasmic vesicles were observed in the infected PAM; no budding was demonstrated at the level of the cytoplasmic membrane. The extracellular virions appeared as pleomorphic but mostly spherical enveloped particles, 50-72 nm in diameter (averaged diameter of 50 particles was 58.3 nm), with an isometric core about 25-30 nm. Buoyant density of the virus in CsCL density gradients was estimated to 1.18-1.20 g/mL. No hemagglutinating activity was demonstrated. Analysis of semipurified virions of isolate IAF-exp91 by radioimmunoprecipitation (RIPA) and Western immunoblotting experiments, using reference rabbit and porcine hyperimmune sera, revealed four major viral proteins, a predominant 15 kD N protein and three other proteins with predicted M(r_ of 19, 26 and 42 kD. Progeny viral particles produced in PRRSV-infected PAM in the presence of tunicamycin lacked the 42 kD protein, thus confirming its N-glycosylated nature. Immunoprecipitation experiments using the anti-ATCC-VR2332 MoAbs confirmed the close antigenic relationships between Quebec and American reference isolates of PRRSV.     

鸡新城疫、传染性支气管炎、禽流感(H9亚型)三联灭活疫苗对禽流感H9亚型流行株攻毒的保护作用

为了监测鸡新城疫、传染性支气管炎、禽流感(H9亚型)三联灭活疫苗(LaSota株+M41株+SS/94株)对H9亚型禽流感病毒流行毒株的免疫保护效果,采用H9亚型禽流感病毒SS/94株及2009—2010年现地分离的3株H9亚型禽流感病毒对已免疫上述三联灭活苗的SPF鸡进行攻毒试验。结果显示,试验鸡以0.3 mL/只的剂量免疫三联灭活苗后21 d,其H9亚型禽流感病毒的HI抗体效价可达8～11log2,此抗体水平可抵抗2×106EID50的H9亚型禽流感病毒SS/94株、BLCN09株、WDZ09株、YT10株的攻击,攻毒保护率均达90%(9/10)以上。可见,以SS/94株作为禽流感疫苗抗原制备的三联灭活苗具有良好的免疫原性,能使免疫鸡抵抗2009—2010年期间现地分离的多株H9亚型禽流感病毒的攻击。     

Immunological reactions of Rift Valley fever virus strains from East and West Africa.

Three strains of Rift Valley fever virus, namely Nigerian (NIG), Smithburn's neurotropic (SNT), and Lunyo variant (LUN) were compared by complement fixation (CF), neutralisation (N), haemagglutination/haemagglutination-inhibition (HA/HI) and agar gel diffusion (AGD) tests. They showed reciprocal cross-reactivity in CF tests. In N tests, using immune sheep sera, there was reciprocal cross-neutralisation between the NIG and SNT strains, but not with the LUN strain, the antiserum of which neutralised both NIG and SNT antigens whereas the reverse was not the case. When hyperimmune mouse ascitic fluid was employed in N tests, there was cross-reactivity between the three strains. Both the NIG and SNT strains yielded haemagglutinins, but not the LUN strain. Furthermore, by the antibody absorption and AGD techniques, the NIG and SNT strains were found to be identical and distinct from the LUN variant strain. The techniques found most useful in distinguishing between the three strains were HA and AGD. Laboratory neuro-adaptation of the classical pantropic virus did not appear to affect its haemagglutination activity.     

Screening for antibodies against infectious bronchitis virus: specificity of the haemagglutination inhibition test

A screening of antibodies against strain M-41 and the Dutch variant strains D-274 and D-1466 of infectious bronchitis virus (IBV) using the haemagglutination inhibition test (HI) was carried out in Chile. The presence of these variant strains has not been reported yet and therefore the probability of finding positive flocks is low. On this basis some statistical analysis were made with those data obtained in order to contribute to the problem of the specificity of the HI test for IBV diagnosis. All sera were distributed in different categories of possible results against each strain according with the HI titre obtained and employing different discrimination levels for a positive or negative status against IBV. It was concluded that discrimination levels varying from 4.0 to 5.0 log2 are useful for establishing the presence or absence of antibodies against IBV but if a serotype specific diagnosis is needed, then the discrimination level should be elevated, specially when secondary immune responses are measured.     

新城疫病毒HN蛋白单克隆抗体的制备

为制备新城疫病毒HN蛋白的单克隆抗体,本研究采用新城疫病毒CK/AH/100/2010作为免疫原,免疫6~8周龄BALB/c小鼠,3次免疫后取脾细胞与SP2/0融合,用血凝抑制(HI)方法检测筛选,具有HI活性的单抗有6株:PX1-PX6。6株单抗与AIV、EDS等其它具有血凝活性的病毒的交叉血凝抑制试验结果表明,6株单抗具有良好的特异性。间接免疫荧光试验结果表明,PX1、PX3可与新城疫病毒CK/GD/263/2010 HN抗原发生特异性反应,而其它单抗不反应。     

H9N2亚型禽流感病毒抗原性变异的研究

对1998—2002年间在河南省豫北地区分离到的5株H9N2亚型禽流感病毒的抗原性变异进行了研究。经HI试验、鸡胚中和试验、细胞中和试验及攻毒保护试验证明，5株H9N2亚型间已经发生了抗原性漂移。98A5和99S毒株间的保护力接近100％，HI试验、鸡胚中和试验、细胞中和试验的相关性均在0．74以上。表明2毒株间的抗原性相近；用00Y毒株攻击其他4株免疫的鸡，其保护率仅为60％～80％；而02Y株对除00Y株外的4株的免疫保护率分别为60％、75％、80％、100％，与分离年代呈负相关性，HI、鸡胚中和试验、细胞中和试验也取得类似结果，说明2000年后的毒株间已发生抗原性变异。     

马流感病毒血凝素基因甲病毒复制子重组表达质粒的构建及其免疫效力评价

为评价马流感病毒(EIV)HA基因核酸免疫效果,本研究以甲病毒复制子载体pSFV1CS分别构建了表达EIV H3N8亚型的美洲型和欧洲型HA基因的重组真核表达质粒。并将其转染293T细胞,经间接免疫荧光鉴定表明HA基因获得表达;以重组质粒免疫的BALB/c鼠能够检测到特异性抗体产生,而且HI抗体水平持续升高,同时小鼠体内IFN-γ、IL-4分泌水平也有所升高。攻毒后小鼠表现轻度临床症状,但病毒分离和RT-PCR均未检测到病毒。上述结果表明,该重组质粒pSFV1CS-EIV-HA具有良好的免疫原性并且可以诱导免疫动物产生较高免疫应答的能力。     

5株H9N2亚型禽流感病毒血凝素蛋白分子特征分析和豚鼠间传播能力的评估

为研究H9N2亚型禽流感病毒(AIV)在哺乳动物间的传播能力,本研究以豚鼠为模型评价了5株H9N2亚型AIV在豚鼠体内的复制能力和水平传播能力,并分析了5株病毒血凝素(HA)蛋白的分子特征。结果表明,5株病毒均属于CK/Beijing谱系,其中2株病毒的HA具有人样受体特征(Lys226),2株病毒具有禽样受体特征(Gln226),而A/Chicken/JN/Li-2/2010(H9N2)株在该位点的氨基酸残基为苯丙氨酸(Phe226)。裂解位点分析表明,5株病毒均具有低致病性AIV特征。个别病毒的潜在糖基化位点存在增加或缺失现象。感染试验表明,5株病毒均能够在豚鼠呼吸道复制。并且在鼻甲骨处复制稳定,平均病毒滴度为2.01 Log EID50/mL～4.5 Log EID50/mL。传播试验表明,所有病毒株的人工接种豚鼠的鼻洗液中均能够检测到病毒,最长排毒期为接毒后第8 d,而接触组豚鼠鼻洗液中未检测到病毒。本研究表明,5株H9N2亚型AIV均属于CK/Beijing谱系,部分病毒株的HA蛋白已具备人样受体结合特征,并且关键氨基酸位点(226位)处出现新的突变。5株病毒均能够在豚鼠呼吸道复制并通过上呼吸道排毒,但不能在豚鼠间同群传播。     

禽流感病毒血凝素糖蛋白(HA)的结构及其生物学功能

高致病性禽流感 (AI)是由禽流感病毒(AIV)引起的一种急性传染病。AIV呈球形 ,有囊膜。其表面主要有两种糖蛋白 ,其中血凝素(hemagglutinin ,HA)具有重要功能 :能凝集红细胞 ,属I型糖蛋白 ;具有株和亚型的特异性 ,是AIV型和亚型内新变种判断的主要依据 ;能结合宿主唾液酸之类的细胞受体 ;HA在病毒吸附及穿膜过程中起关键作用 ,HA上裂解位点的序列直接影响AI病毒致病性的高低 ;HA的变异性很强 ,它的变异是AI病毒发生抗原变异的主要原因 ,HA是最主要的抗原物质。因此HA对AIV的生物学特征具有十分重要的意义     

鸡胚中新城疫强毒的分离、鉴定与生物学特性研究

将来自有产蛋下降表现的一个肉用型父母代种鸡群的种蛋在实验室内孵化,每日观察鸡胚死亡情况。在孵化的24个鸡胚中有2个在孵化后8~9 d死亡,尿囊液有血凝性。在HI试验中,NDV单因子血清呈现26的HI滴度,对H9和H5亚型AIV单因子血清不呈血凝抑制活性,由此确定为新城疫病毒(Newcastle disease virus,NDV),分别命名为Tengz060104和Tengz060107。对该2个NDV分离株的生物学毒力指标进行测定,Tengz060104株的MDTI、CPI和IVPI分别为56.4 h、1.88和2.67,Tengz060107株的MDTI、CPI和IVPI分别为40.8 h、1.88和2.79。在6周龄SPF鸡攻毒后产生典型的ND症状的病变。表明来自鸡胚的2个分离株属强毒力、速发型NDV毒株。交叉HI中Tengz060104和Tengz060107相互间的同源性为100%,而与经典NDV毒株F48E8的同源性比较分别是66.7%和57.7%。从鸡胚中分离到新城疫强毒株在国内尚未见报道。